Marketing-authorisation holder · United States
Nordic Grp
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| REDITREX10mg/0.4ml (10mg/0.4ml) | 12.5mg/0.5ml (12.5mg/0.5ml) | 15mg/0.6ml (15mg/0.6ml) | 17.5mg/0.7ml (17.5mg/0.7ml) | 20mg/0.8ml (20mg/0.8ml) | 22.5mg/ml (22.5mg/ml) | 25mg/1ml (25mg/1ml) | 7.5mg/0.3ml (7.5mg/0.3ml) · Solution | Methotrexate | United States | Not marketed | 2019 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.